Days after filing its Chapter 11 paperwork, the San Diego-based biotech said a bankruptcy court in Texas has granted interim approval for a $75 million financing that will fund its operations while it sorts out its financial troubles.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,